Please use this identifier to cite or link to this item:
Title: Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Filiation: Instituto de Investigación Sanitaria Gregorio Marañón
Keywords: Triple-Negative Breast Cancer
Issue Date: 2018
Citation: Clin Cancer Res.2018 12;(24)23:5820-5829
Abstract: Prognostic value of pathologic complete response (pCR) and extent of pathologic response attained with anthracycline-free platinum plus taxane neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) is unknown. We report recurrence-free survival (RFS) and overall survival (OS) according to degree of pathologic response in patients treated with carboplatin plus docetaxel NAC.
PMID: 30061361
Rights: info:eu-repo/semantics/openAccess
ISSN: 1557-3265
Appears in Collections:Hospitales > H. U. Gregorio Marañón > Artículos

Files in This Item:
File Description SizeFormat 
5820.full.pdf500.3 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.